化合物VER-246608 T17224
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
25 mg | 1684386-71-7 | ¥3,490.00 | 询底价 |
1 mL | 1684386-71-7 | ¥1,410.00 | 询底价 |
1 mg | 1684386-71-7 | ¥493.00 | 询底价 |
2 mg | 1684386-71-7 | ¥716.00 | 询底价 |
50 mg | 1684386-71-7 | ¥4,970.00 | 询底价 |
5 mg | 1684386-71-7 | ¥1,150.00 | 询底价 |
100 mg | 1684386-71-7 | ¥7,230.00 | 询底价 |
10 mg | 1684386-71-7 | ¥1,820.00 | 询底价 |
Product Introduction
Bioactivity
英文名: VER-246608
描述: VER-246608 是ATP 竞争性的丙酮酸脱氢酶激酶抑制剂,对PDK-1,PDK-3,PDK-2,和PDK-4的IC50分别为 35 nM,40 nM,84 nM 和 91 nM。
体外活性: A novel and selective ATP competitive pan-isoform inhibitor of PDK, VER-246608.?Consistent with a PDK mediated MOA, VER-246608 increased pyruvate dehydrogenase complex (PDC) activity, oxygen consumption and attenuated glycolytic activity.?However, these effects were only observed under D-glucose-depleted conditions and required almost complete ablation of PDC E1α subunit phosphorylation.?VER-246608 was weakly anti-proliferative to cancer cells in standard culture media
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 50 mg/mL (90.42 mM)
关键字: Inhibitor | PDHK | VER-246608 | VER246608 | Pyruvate dehydrogenase kinase | inhibit | PDH kinase | VER 246608
相关产品: 6''-O-Acetylglycitin | Metyrapone | PKUMDL-WQ-2101 | Tenovin-1 | FX-11 | Rotenone | DHODH-IN-11 | DHODH-IN-13 | Bipenquinate | D-Mannitol
相关库: Anti-Prostate Cancer Compound Library | Glycometabolism Compound Library | Oxidation-Reduction Compound Library | Anti-Cancer Compound Library | Neuronal Differentiation Compound Library | Antidepressant Compound Library | Kinase Inhibitor Library | Inhibitor Library | Metabolism Compound Library | Anti-Pancreatic Cancer Compound Library
化合物VER-246608 T17224信息由TargetMol中国为您提供,如您想了解更多关于化合物VER-246608 T17224报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途